India’s Burmans Return To Trial Outsourcing With OneQuest
This article was originally published in PharmAsia News
Executive Summary
The Burman family, formerly of India's Dabur Pharma, is considering a return to the medical business with its privately held company, OneQuest. The firm plans to provide molecular diagnostics for the world's major drug-research and outsourced clinical-trial companies in all therapeutic areas. OneQuest has been focusing its business on test services for oncological clinical trials. Sources say OneQuest also plans eventually to conduct trials itself. The diagnostics business used to be a part of Dabur Pharma, but was transferred to OneQuest before Fresenius Kabi bought Dabur. (Click here for more